المؤلفون: Ding, Ling-Wen, Sun, Qiao-Yang, Edwards, Jarem J, Fernández, Lucia Torres, Ran, Xue-Bin, Zhou, Si-Qin, Scolyer, Richard A, Wilmott, James S, Thompson, John F, Doan, Ngan, Said, Jonathan W, Venkatachalam, Nachiyappan, Xiao, Jin-Fen, Loh, Xin-Yi, Pein, Maren, Xu, Liang, Mullins, David W, Yang, Henry, Lin, De-Chen, Koeffler, H Phillip

المصدر: Nature communications. 10(1)

مصطلحات موضوعية: Cell Line, Tumor, Animals, Mice, Inbred C57BL, Mice, Inbred NOD, Humans, Mice, Mice, SCID, Melanoma, Skin Neoplasms, Intracellular Signaling Peptides and Proteins, Proteins, Interferons, Xenograft Model Antitumor Assays, Apoptosis, STAT1 Transcription Factor, HEK293 Cells, Cell Cycle Checkpoints, Membrane Proteins, Cell Line, Tumor, Inbred C57BL, Inbred NOD, SCID

وصف الملف: application/pdf

URL الوصول: https://escholarship.org/uc/item/69k6p1m2

المؤلفون: Bawden, Emma G., Wagner, Teagan, Schröder, Jan, Effern, Maike, Hinze, Daniel, Newland, Lewis, Attrill, Grace H., Lee, Ariane R., Engel, Sven, Freestone, David, de Lima Moreira, Marcela, Gressier, Elise, McBain, Nathan, Bachem, Annabell, Haque, Ashraful, Dong, Ruining, Ferguson, Angela L., Edwards, Jarem J., Ferguson, Peter M., Scolyer, Richard A.

المصدر: Science Immunology; 2024, Vol. 9 Issue 91, p1-18, 18p

مصطلحات موضوعية: T cells, CYTOTOXIC T cells, NITRIC-oxide synthases, MYELOID cells, MAJOR histocompatibility complex, HUMORAL immunity, GRAFT versus host reaction

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Ling-Wen Ding, Qiao-Yang Sun, Edwards, Jarem J., Fernández, Lucia Torres, Xue-Bin Ran, Si-Qin Zhou, Scolyer, Richard A., Wilmott, James S., Thompson, John F., Ngan Doan, Said, Jonathan W., Venkatachalam, Nachiyappan, Jin-Fen Xiao, Xin-Yi Loh, Maren Pein, Liang Xu, Mullins, David W., Henry Yang, De-Chen Lin, Koeffler, H. Phillip

المصدر: Nature Communications; 5/20/2019, Vol. 10 Issue 1, p1-13, 13p, 1 Diagram, 5 Graphs

المؤلفون: Edwards, Jarem J., Tasker, Annie, Allanson, Benjamin M., Saw, Robyn P.M., Thompson, John F., Palendira, Umaimainthan, Menzies, Alexander M., Long, Georgina V., Scolyer, Richard A., Wilmott, James S.

المصدر: In Pathology February 2019 51 Supplement 1:S154-S155

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Bawden EG; Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.; Institute of Experimental Oncology (IEO), Medical Faculty, University Hospital Bonn, University of Bonn, Bonn 53105, Germany., Wagner T; Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia., Schröder J; Computational Sciences Initiative, Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia., Effern M; Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.; Institute of Experimental Oncology (IEO), Medical Faculty, University Hospital Bonn, University of Bonn, Bonn 53105, Germany., Hinze D; Institute of Experimental Oncology (IEO), Medical Faculty, University Hospital Bonn, University of Bonn, Bonn 53105, Germany., Newland L; Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.; Institute of Experimental Oncology (IEO), Medical Faculty, University Hospital Bonn, University of Bonn, Bonn 53105, Germany., Attrill GH; Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.; Charles Perkins Centre, University of Sydney, Sydney, NSW, Australia., Lee AR; Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia., Engel S; Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia., Freestone D; Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia., de Lima Moreira M; Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia., Gressier E; Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia., McBain N; Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia., Bachem A; Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia., Haque A; Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia., Dong R; Computational Sciences Initiative, Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.; Department of Clinical Pathology and Centre for Cancer Research, University of Melbourne, Melbourne, VIC, Australia., Ferguson AL; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.; Charles Perkins Centre, University of Sydney, Sydney, NSW, Australia.; Centenary Institute, University of Sydney, Sydney, NSW, Australia.; Infection, Immunity and Inflammation theme, School of Medical Sciences, Charles Perkins Centre, University of Sydney, Sydney, NSW, Australia., Edwards JJ; Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.; Charles Perkins Centre, University of Sydney, Sydney, NSW, Australia., Ferguson PM; Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.; Department of Tissue Oncology and Diagnostic Pathology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.; NSW Health Pathology, Sydney, NSW, Australia., Scolyer RA; Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.; Charles Perkins Centre, University of Sydney, Sydney, NSW, Australia.; Department of Tissue Oncology and Diagnostic Pathology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.; NSW Health Pathology, Sydney, NSW, Australia., Wilmott JS; Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.; Charles Perkins Centre, University of Sydney, Sydney, NSW, Australia., Jewell CM; Fischell Department of Bioengineering, University of Maryland, College Park, MD, USA.; United States Department of Veterans Affairs, VA Maryland Health Care System, Baltimore, MD, USA.; Robert E. Fischell Institute for Biomedical Devices, College Park, MD, USA.; Marlene and Stewart Greenebaum Cancer Center, Baltimore, MD, USA., Brooks AG; Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia., Gyorki DE; Division of Cancer Surgery, Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Peter MacCallum Cancer Centre Melbourne, Melbourne, VIC, Australia., Palendira U; Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.; Charles Perkins Centre, University of Sydney, Sydney, NSW, Australia., Bedoui S; Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia., Waithman J; Telethon Kids Institute, University of Western Australia, Perth, WA, Australia.; School of Biomedical Sciences, University of Western Australia, Perth, WA, Australia., Hochheiser K; Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.; Peter MacCallum Cancer Centre Melbourne, Melbourne, VIC, Australia., Hölzel M; Institute of Experimental Oncology (IEO), Medical Faculty, University Hospital Bonn, University of Bonn, Bonn 53105, Germany., Gebhardt T; Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.

المصدر: Science immunology [Sci Immunol] 2024 Jan 19; Vol. 9 (91), pp. eadi9517. Date of Electronic Publication: 2024 Jan 19.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101688624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2470-9468 (Electronic) Linking ISSN: 24709468 NLM ISO Abbreviation: Sci Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Melanoma* , Skin Neoplasms*, Humans ; CD8-Positive T-Lymphocytes ; CD4-Positive T-Lymphocytes ; Histocompatibility Antigens Class II ; HLA Antigens

المؤلفون: Newell F; QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia., Pires da Silva I; Melanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia; Charles Perkins Centre, The University of Sydney, Sydney, NSW 2006, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia; Cancer Centre, Blacktown Hospital, Sydney, NSW 2148, Australia., Johansson PA; QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia., Menzies AM; Melanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia; Department of Medical Oncology, Royal North Shore Hospital, Sydney, NSW 2065, Australia; Mater Hospital, Sydney, NSW 2060, Australia., Wilmott JS; Melanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia; Charles Perkins Centre, The University of Sydney, Sydney, NSW 2006, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia., Addala V; QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia; Faculty of Medicine, The University of Queensland, Brisbane, QLD 4072, Australia., Carlino MS; Melanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia; Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney, Westmead, NSW 2145, Australia; Department of Medical Oncology, Westmead Hospital, Sydney, NSW 2145, Australia., Rizos H; Faculty of Medicine, Health and Human Sciences, Macquarie University, North Ryde, NSW 2109, Australia., Nones K; QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia., Edwards JJ; Melanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia; Charles Perkins Centre, The University of Sydney, Sydney, NSW 2006, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia., Lakis V; QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia., Kazakoff SH; QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia., Mukhopadhyay P; QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia., Ferguson PM; Melanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Camperdown, NSW 2050, Australia., Leonard C; QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia., Koufariotis LT; QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia., Wood S; QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia., Blank CU; Department of Molecular Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Thompson JF; Melanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia; Mater Hospital, Sydney, NSW 2060, Australia; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia., Spillane AJ; Melanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia; Mater Hospital, Sydney, NSW 2060, Australia., Saw RPM; Melanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia; Mater Hospital, Sydney, NSW 2060, Australia; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia., Shannon KF; Melanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia; Mater Hospital, Sydney, NSW 2060, Australia; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia., Pearson JV; QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia., Mann GJ; Melanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia; Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney, Westmead, NSW 2145, Australia; John Curtin School of Medical Research, Australian National University, ACT 2601, Australia., Hayward NK; QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia., Scolyer RA; Melanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia; Charles Perkins Centre, The University of Sydney, Sydney, NSW 2006, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Camperdown, NSW 2050, Australia., Waddell N; QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia; Faculty of Medicine, The University of Queensland, Brisbane, QLD 4072, Australia., Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia; Charles Perkins Centre, The University of Sydney, Sydney, NSW 2006, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia; Department of Medical Oncology, Royal North Shore Hospital, Sydney, NSW 2065, Australia; Mater Hospital, Sydney, NSW 2060, Australia. Electronic address: georgina.long@melanoma.org.au.

المصدر: Cancer cell [Cancer Cell] 2022 Jan 10; Vol. 40 (1), pp. 88-102.e7. Date of Electronic Publication: 2021 Dec 23.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents, Immunological/*therapeutic use , Carcinoma, Non-Small-Cell Lung/*drug therapy , Lung Neoplasms/*drug therapy , Melanoma/*drug therapy , Skin Neoplasms/*drug therapy, B7-H1 Antigen/immunology ; Biomarkers, Tumor/genetics ; CTLA-4 Antigen/immunology ; Carcinoma, Non-Small-Cell Lung/immunology ; Humans ; Immunotherapy/methods ; Lung Neoplasms/genetics ; Lung Neoplasms/immunology ; Melanoma/immunology ; Mutation/genetics ; Skin Neoplasms/immunology ; Tumor Microenvironment/immunology ; Melanoma, Cutaneous Malignant